Voltadol Forte Schmerzgel

Voltadol (known as Voltaren in many other countries) is a leading brand in the field of pain relief, specifically known for its topical diclofenac gels. The name 'Voltadol' is the specific branding used in the Austrian market for this analgesic product.

The brand was originally developed by the Swiss pharmaceutical company Ciba-Geigy, which later merged to become Novartis. In a major strategic shift for the consumer healthcare sector, Novartis and GSK combined their consumer health units, which eventually resulted in the spin-off of Haleon in 2022.

Today, Haleon operates as an independent, globally leading consumer health company based in the United Kingdom. Manufacturing for the European market primarily occurs in specialized pharmaceutical facilities in Germany and Switzerland, ensuring strict quality standards for this medical-grade product.